Factors influencing the development of end-stage renal disease

被引：36
作者：
Iseki K. [1 ]
机构：
[1] Dialysis Unit, University Hospital of the Ryukyus, Nishihara, Okinawa 903-0215
来源：
Clinical and Experimental Nephrology | 2005年 / 9卷 / 1期
关键词：
End-stage renal disease; ESRD; Hematuria; Hypertension; Proteinuria; Screening;
D O I：
10.1007/s10157-005-0341-3
中图分类号：
学科分类号：
摘要：
Epidemiological evidence is needed to design effective strategies for preventing chronic kidney disease (CKD) and end-stage renal disease (ESRD). Several types of health check are routinely performed in Japan, including the screening of asymptomatic individuals, but the potential benefits of these procedures remain unknown. We evaluated the predictors of ESRD, using community-based mass screening and a dialysis registry. This approach revealed the significance of proteinuria, hypertension, obesity, anemia, and high fasting plasma glucose levels (which indicate diabetes mellitus; DM), for the risk of developing ESRD. Lifestyle-related factors, such as smoking, alcohol consumption, and low levels of exercise, are also associated with these conditions and, in particular, with a high risk of ESRD. Over-nutrition and low levels of exercise can ultimately lead to DM, hypertension, hyperlipidemia, and obesity, and are important risk factors worldwide for cardiovascular diseases, CKD, and ESRD. The early detection and treatment of predictors of ESRD, along with appropriate treatment for CKD, may decrease the incidence of ESRD. In addition, the economic burden caused by the costs of dialysis presents a compelling argument for implementing a cost-effective preventive strategy against ESRD. © Japanese Society of Nephrology 2005.
引用
收藏
页码：5 / 14
页数：9
相关论文
共 100 条
[1]  
Nakai S., Shinzato T., Sanaka T., Kikuchi K., Kitaoka T., Shinoda T., Et al., The current state of chronic dialysis treatment in Japan (as of December 31, 2000), J Jpn Soc Dial Ther, 35, pp. 1155-1184, (2002)
[2]  
Excerpts from the USRDS 2001 Annual Data Report: Atlas of end-stage renal disease in the United States, Am J Kidney Dis, 38, 3 SUPPL., (2001)
[3]  
Schena F.P., Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy, Kidney Int, 57, 74 SUPPL., (2000)
[4]  
Usami T., Koyama K., Takeuchi O., Morozumi K., Kimura G., Regional variation in the incidence of end-stage renal failure in Japan, JAMA, 284, pp. 2622-2624, (2000)
[5]  
Yamagata K., Takahashi H., Suzuki S., Mase K., Hagiwara M., Shimizu Y., Et al., Age distribution and yearly changes in the incidence of ESRD in Japan, Am J Kidney Dis, 43, pp. 433-443, (2004)
[6]  
Yamagata K., Yamagata Y., Kobayashi M., Koyama A., A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults, Clin Nephrol, 45, pp. 281-288, (1996)
[7]  
Murakami M., Yamamoto H., Ueda Y., Murakami K., Yamauchi K., Urinary screening of elementary and junior high-school children over a 13-year period in Tokyo, Pediatr Nephrol, 5, pp. 50-53, (1991)
[8]  
Iseki K., Iseki C., Ikemiya Y., Fukiyama K., Risk of developing end-stage renal disease in a cohort of mass screening, Kidney Int, 49, pp. 800-805, (1996)
[9]  
Iseki K., Ikemiya Y., Fukiyama K., Blood pressure and risk of end-stage renal disease in a screened cohort, Kidney Int, 49, 55 SUPPL., (1996)
[10]  
Iseki K., Ikemiya Y., Fukiyama K., Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening, Kidney Int, 51, pp. 850-854, (1997)
12345678910